SPIRITT Research Becomes Latest CRO To Join MedNet Solutions' iMedNet Partner Program
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE MedNet Solutions
SPIRITT Selects iMedNet™ EDC for its Superior eClinical Flexibility and Ease of Use
MINNETONKA, Minn., Dec. 11, 2013 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that SPIRITT Research, a boutique research services organization with a passion for improving patient treatment outcomes and quality of life, has joined MedNet's iMedNet Partner Program. SPIRITT will leverage iMedNet EDC, MedNet's flagship eClinical solution, to get their research studies set up quickly, easily and cost-effectively.
"SPIRITT is an ideal partner for MedNet, given our companies' deep, shared expertise supporting orthopedic and spine related research, as well as post market studies and registries," remarked John M. (Rob) Robertson, President and CEO of MedNet Solutions. "We're confident that our organizations will work very well together and that iMedNet EDC will provide SPIRITT with the technology infrastructure they need to facilitate effective and efficient research."
"We are very pleased to be partnering with MedNet Solutions," commented Francine Schranck, President of SPIRITT. "The iMedNet product is one of the best clinical trial management systems we've seen, and we recommend it without reservation."
Matthew Britt, Director of Clinical Affairs at SPIRITT, added, "We are asked all the time by our clients about the best solutions to support them in their various clinical trials, and because of its flexibility and ease of use, iMedNet is a logical choice."
SPIRITT is a specialty clinical research team focused on collecting high-quality patient-informed evidence in the medical device, biologic and pharmaceutical industries. SPIRITT Research offers full or a la carte services for medical practices (community-based and academic) and industry sponsors, including: clinical study development and execution services; subject engagement and compliance; regulatory guidance; product development; educational training/support services; abstract preparation/podium presentation assistance and peer-reviewed journal publication assistance. It is SPIRITT's goal to help researchers and clinicians collect evidence that will improve healthcare outcomes for patients while meeting the needs of other stakeholders, including healthcare providers, payers and medical technology companies. For more information, please visit www.spirittresearch.com.
About MedNet Solutions
MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical trial management systems (CTMS) designed for the global life sciences market. MedNet delivers proven, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials of all types and sizes. Since 2001, MedNet has successfully supported pharmaceutical, medical device, biotechnology and contract research organizations (CROs) on clinical research conducted around the world. These companies trust MedNet to consistently deliver the technology innovation, experience and reliability they need for success. For more information, please visit www.mednetstudy.com.
Contact Information Dirk H. Nelson Director of Marketing MedNet Solutions 110 Cheshire Lane, Suite 300 Minnetonka, MN 55305 USA
Francine W. Schranck President SPIRITT Research 12977 North Forty Drive, Suite 200 St. Louis, MO 63141 USA
People fighting cancer might have to wait longer to see a cancer specialist in the coming decades, as demand for treatment outpaces the number of oncologists entering the workforce, a new report released Tuesday...More >>
People fighting cancer might have to wait longer to see a cancer specialist in the coming decades, as demand for treatment outpaces the number of oncologists entering the workforce, a new report released Tuesday warns.More >>